David Stegner

Title: The Innovations of David Stegner

Introduction

David Stegner is an accomplished inventor based in Würzburg, Germany. He is known for his significant contributions to the field of medical science, particularly in the treatment of thrombotic diseases. His innovative approach has led to the development of a unique soluble polypeptide that has the potential to improve patient outcomes.

Latest Patents

Stegner holds a patent for a soluble glycoprotein V, which is designed for treating thrombotic diseases. This patent describes a soluble polypeptide comprising a modified glycoprotein V (GPV) that lacks a functional transmembrane domain. The invention aims to provide an effective treatment or prevention method for thrombotic diseases by administering an effective amount of the soluble polypeptide to the subject.

Career Highlights

Throughout his career, David Stegner has worked with prestigious institutions, including Julius-Maximilians-Universität Würzburg. His work at this university has allowed him to engage in groundbreaking research and contribute to advancements in medical science.

Collaborations

Stegner has collaborated with notable colleagues such as Bernhard Nieswandt and Sarah Beck. These partnerships have further enriched his research and innovation efforts.

Conclusion

David Stegner's contributions to the field of thrombotic disease treatment exemplify the impact of innovative thinking in medical science. His patent for a soluble glycoprotein V represents a significant advancement that could benefit many patients in need.